Inventor · disambiguated record
Michael Thiele
Also filed as: THIELE MICHAEL · THIELE MICHAEL ROBERT
5 granted patents·7 pending applications·26 citations·filing 1990–2022
72Inventor score
Top patents by PatentIndex Score
12 records- 0178US8668909B2Anti MIF antibodiesKERSCHBAUMER RANDOLF·Filed 2010·Granted Mar 11, 2014·5 cites·17 claims
- 0271US5128495AProcess for the preparation of alkylphosphonous acid diesters and/or dialkylphosphinous acid estersHOECHST AG·Filed 1990·Granted Jul 7, 1992·20 cites·8 claims
- 0365US9958456B2OxMIF as a diagnostic markerBaxalta GmbH·Filed 2012·Granted May 1, 2018·1 cites·11 claims
- 0457US2009220521A1Anti MIF AntibodiesKERSCHBAUMER RANDOLF·Filed 2008·Application pending·0 cites
- 0553US2015023978A1Anti mif antibodiesBAXTER INT·Filed 2014·Application pending·0 cites
- 0648US2025129148A1IMPROVED Fc SILENCED ANTI-oxMIF ANTIBODIES WITH REDUCED AGGREGATION POTENTIAL AND REDUCED HYDROPHOBICITYONCOONE RES & DEVELOPMENT GMBH·Filed 2022·Application pending·0 cites
- 0745US2015309012A1Anti-mif antibody cell migration assayBAXTER INT·Filed 2013·Application pending·0 cites
- 0844US2023045873A1ANTI-oxMIF/ANTI-CD3 BISPECIFIC ANTIBODY CONSTRUCTSONCOONE RES & DEVELOPMENT GMBH·Filed 2020·Application pending·0 cites
- 0943US11402388B2Anti-MIF immunohistochemistryTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Aug 2, 2022·0 cites·15 claims
- 1039US2022002398A1ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENTONCOONE RES & DEVELOPMENT GMBH·Filed 2019·Application pending·0 cites
- 1135US2018155419A1Anti-mif antibodies in the treatment of cancers containing mutant tp53 and/or mutant rasBaxalta GmbH·Filed 2016·Application pending·0 cites
- 1232US10613100B2Anti-MIF immunohistochemistryBAXALTA INC·Filed 2015·Granted Apr 7, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Michael Thiele files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →